Ansulin R (40 IU/ml) 40i.u/ml

Overview

Ansulin R contains Regular Insulin Human (rDNA), a short-acting insulin manufactured by Square Pharmaceuticals PLC, used to control postprandial blood glucose levels in patients with diabetes mellitus.

Dosage and Administration

Dose is individualized based on blood glucose monitoring, typically given subcutaneously 15-30 minutes before meals, two to three times daily. Can also be given intravenously under medical supervision in emergencies such as diabetic ketoacidosis.

Interaction

Beta-blockers, MAO inhibitors, and alcohol may potentiate hypoglycaemic effects. Corticosteroids and thiazide diuretics may reduce insulin's effect.

Contraindications

Contraindicated in patients with hypoglycaemia and known hypersensitivity to insulin human.

Side Effects

Hypoglycaemia, injection site reactions, and lipodystrophy. Allergic reactions are rare.

Pregnancy and Lactation

Insulin is the treatment of choice during pregnancy and lactation; dose adjustment under medical supervision may be required.

Precautions and Warnings

This is a clear solution; do not use if it appears cloudy or discoloured. Monitor blood glucose regularly, particularly when changing dose or insulin regimen.

Storage Conditions

Store in a refrigerator (2-8°C); do not freeze. Once in use, keep below 30°C for up to 4 weeks, protected from light and heat.

Frequently Asked Questions

How quickly does Ansulin R act?
It begins lowering blood glucose within 30 minutes, with peak effect at 1-3 hours and duration of about 6-8 hours.

Can it be given intravenously?
Yes, in emergency settings such as diabetic ketoacidosis, it may be given intravenously under direct medical supervision.

This content is for informational purposes only and does not substitute professional medical advice. Please consult a registered physician before taking any medication.